N
Noblegen
Advanced ingredients company that produces unique proteins and oils for the healthy living industry
About Noblegen
Noblegen is a pioneering life sciences company dedicated to creating sustainable solutions that challenge conventional practices. The company operates in the biotechnology sector, focusing on innovative products that have a positive impact on both human health and the environment. Noblegen serves a diverse range of clients, including food and beverage manufacturers, health and wellness companies, and other industries seeking sustainable alternatives. The business model revolves around leveraging its proprietary Euglena-based technology to develop and commercialize groundbreaking products. Revenue is generated through the sale of these innovative solutions and through strategic partnerships and collaborations.
Read full description
Noblegen's market is global, targeting industries that are increasingly prioritizing sustainability and health. The company's unique approach involves questioning norms and taking non-linear paths to solve complex global problems. This strategy not only sets them apart but also accelerates the development of impactful solutions.
At a glance
- Status
- Acquired
- Founded
- 2013
- Headquarters
- Peterborough, Canada
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 62.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Innovative Food
- Sector
- Biotech & Life Sciences, Biotechnology, Sports Nutrition, Microbiology, Nutrition, Bioreactors, Synthetic Biology, Spinout, Alternative Protein, Sustainable Development Goals
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jul 2023 | $0 | — | Solar Biotech | ↗ |
| SERIES B✓Equity / VC | May 2019 | $18M | $72M | BDC Capital · Business Development Bank of Canada · Richardson Ventures | — |
Growth signals
Latest recorded traffic for Noblegen is 1.6K monthly website visits, up 1500% over the last three months. Noblegen's team declined 61.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Business Development Bank of Canada
BDC Capital- RVRichardson Ventures
Other known investors3 additional known investors
Solar Biotech
Trent University
Arancia International
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Noblegen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Noblegen’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







